|
| ID |
DDInter1526 |
| Drug Type |
small molecule |
| Molecular Formula |
C12H19N3O |
| Molecular Weight |
221.304
|
| Description |
Procarbazine is an antineoplastic agent indicated for the treatment of stage III and stage IV Hodgkin's disease in combination with other chemotherapeutic agents.
|
| ATC Classification |
L01XB01
|
| IUPAC Name |
4-[(2-Methylhydrazin-1-Yl)Methyl]-N-(Propan-2-Yl)Benzamide |
| InChI |
Inchi=1S/C12H19N3O/C1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/H4-7,9,13-14H,8H2,1-3H3,(H,15,16) |
| InChI Key |
CPTBDICYNRMXFX-UHFFFAOYSA-N |
| Canonical SMILES |
CNNCC1=CC=C(C=C1)C(=O)NC(C)C |
| Useful Links |
DrugBank
ChEMBL
PubChem
|